Aranax Medical — Aranax Medical Private Limited
Aranax Medical Private Limited is a Private Non-govt company company incorporated in 2017 and based in Rajasthan, India. It was founded by Ashish, Alok, and Anshul. Aranax Medical Private Limited operates in Medical & Precision (NIC 33309) with authorized capital of ₹10.00 L and paid-up capital of ₹1.00 L. For 2022-23, the company reported revenue of ₹6.17 Cr and profit after tax of ₹1.03 Cr. The board has 3 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Aranax Medical - Provider of in-vitro diagnostics, patient care, and home healthcare products.
Quick facts
Directors
3 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +16d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +17d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Aranax Medical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 382248630 | HDFC Bank Ltd(Bank) | ₹1.29 Cr | 12 Mar 2023 | Open |
| 643243907 | ICICI Bank Ltd(Bank) | ₹1.44 Cr | 04 Jul 2019 | Open |
| 515673817 | State Bank of India(Bank) | ₹22.48 Cr | 12 Mar 2019 | Open |
| 402563819 | Axis Bank Ltd(Bank) | ₹5.60 Cr | 04 Jul 2022 | Open |
| 682822027 | HDFC Bank Ltd(Bank) | ₹17.42 Cr | 27 Jan 2021 | Satisfied |
Charge IDs, lenders & amounts for Aranax Medical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — |
Detailed Financials
4 FYs| Line item | 2022-23 | 2021-22 | 2020-21 | 2018-19 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2022-23 | -2.0% | +874.0% | — | |
| Profit after Tax2022-23 | +94.0% | — | — | |
| Net Worth2022-23 | +955.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2017-18 | -188.30% | — | — | -271.81% | — | |||
| 2018-19 | -18.10% | +819.25% | — | -26.59% | — | |||
| 2020-21 | +11.49% | +254.33% | +447.37% | +21.01% | 21.29 | |||
| 2021-22 | +13.24% | +175.77% | +93.43% | +44.81% | 2.08 | |||
| 2022-23 | +16.64% | -9.09% | +51.63% | +28.82% | 1.79 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 2,34,29,486 | 79.63% |
| Institutional Investors | 3 | 29,90,104 | 10.16% |
| Public & Others | 23 | 30,02,429 | 10.20% |
Promoter, institutional & public holding for Aranax Medical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
20 peersEvents & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.